The HCLS1 Knockout A-549 Polyclonal Cells are a CRISPR/Cas9-edited polyclonal knockout cell population derived from the human lung adenocarcinoma A-549 cell line, enabling loss-of-function studies of the hematopoietic cell-specific Lyn substrate 1 (HCLS1) gene. This heterogeneous pool harbors targeted disruptions of the HCLS1 locus, eliminating functional protein expression. As a polyclonal model, it avoids clonal selection biases, providing a robust system to investigate HCLS1 biology.
The parental A-549 cells originated from a lung adenocarcinoma and serve as a model for type II alveolar epithelial cells. They are commonly used in non-small cell lung cancer research to study oncogenic signaling, drug responses, and epithelial cell behaviors. Although HCLS1 is primarily known in hematopoietic cells, ectopic expression or forced knockout in A-549 cells permits exploration of its roles in actin regulation within an epithelial context, particularly relevant to metastasis.
HCLS1 is a crucial adaptor linking receptor signaling to actin cytoskeleton remodeling. Upon activation of B-cell, T-cell, Fc gamma, or IL-2 receptors, Lyn and Syk kinases phosphorylate HCLS1, which then recruits WASp and the Arp2/3 complex to drive branched actin polymerization. This pathway mediates immune synapse assembly, cell migration, and adhesion. Interacting partners include BLNK, F-actin, and the Arp2/3 complex, positioning HCLS1 downstream of Src/Syk kinases and upstream of actin nucleation.
In A-549 lung adenocarcinoma cells, HCLS1 knockout likely disrupts actin-dependent processes such as stress fiber formation, lamellipodial protrusion, and cell migration??functions central to cancer invasion. This model therefore allows dissection of HCLS1??s contribution to metastatic potential and may reveal non-immune signaling roles. Comparison of wild-type and knockout populations can identify HCLS1-dependent changes in morphology, adhesion, and proliferation.
These knockout cells are suitable for Western blotting and RT-qPCR to confirm HCLS1 depletion, immunofluorescence to visualize F-actin structures, and migration/invasion assays (e.g., Boyden chamber, wound healing). Proliferation and signaling studies can be conducted, using the cells as a negative control for phospho-HCLS1 detection. For additional information, please contact Ascent Research.
